ENTYVIO
Active substance: vedolizumab
INJECTION, SOLUTION · VEDOLIZUMAB 108 mg/.68mL
United StatesActive
Marketing holder: Takeda Pharmaceuticals America, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- VEDOLIZUMAB · 108 mg/.68mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-7440-7452-833b-24513b947dd1,01a12092-492f-7f92-b7ec-0060ed2aaab2,01a1209b-8c47-75b4-86de-6add5ec9cf66;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 64764-107
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 64764-107 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 64764-107 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 64764-107 · Verified 2026-10-09 · open in source